A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF‐2
Open Access
- 5 January 2001
- journal article
- fj express-summary
- Published by Wiley in The FASEB Journal
- Vol. 15 (3) , 550-552
- https://doi.org/10.1096/fj.00-0285fje
Abstract
Platelet factor 4 (PF-4) is a CXC-chemokine with strong anti-angiogenic properties. We have shown previously that PF-4 inhibits angiogenesis by associating directly with fibroblast growth factor 2 (F...Keywords
Funding Information
- Dirección General de Investigación Científica y Técnica
This publication has 42 references indexed in Scilit:
- Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor GrowthJournal of Biological Chemistry, 2000
- Antiangiogenic Activity of the Cleaved Conformation of the Serpin AntithrombinScience, 1999
- Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factorProceedings of the National Academy of Sciences, 1999
- Troponin I is present in human cartilage and inhibits angiogenesisProceedings of the National Academy of Sciences, 1999
- Ocular Neovascularization: Clarifying Complex InteractionsThe American Journal of Pathology, 1998
- High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerInternational Journal of Cancer, 1998
- Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding ActivityCell, 1998
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of CancersJNCI Journal of the National Cancer Institute, 1994